Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>Vance G. Fowler, Sara E. Cosgrove, Christopher H. Cabell et al.|New England Journal of Medicine|2006Cited by 1.5k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe SepsisEdward Abraham, Abla A. Creasey, Konrad Reinhart et al.|JAMA|2003Cited by 958
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialErnst-Rüdiger Kuse, Oliver A. Cornely, Ploenchan Chetchotisakd et al.|The Lancet|2007Cited by 689
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*Todd W. Rice, Jon Cohen, Arthur P. Wheeler et al.|Critical Care Medicine|2010Cited by 500
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*Steven M. Opal, John P. Pribble, Pierre‐François Laterre et al.|Critical Care Medicine|2004Cited by 145